These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26753400)

  • 1. [Kidney aging: a predictable and partly avoidable fragility].
    Laville M; Rognant N
    Bull Acad Natl Med; 2014; 198(4-5):673-88. PubMed ID: 26753400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney Disease and the Aging Population.
    Tonelli M; Riellae M
    Arab J Nephrol Transplant; 2014 Jan; 7(1):7-11. PubMed ID: 24702528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating kidney function and use of oral antidiabetic drugs in elderly.
    Douros A; Ebert N; Jakob O; Martus P; Kreutz R; Schaeffner E
    Fundam Clin Pharmacol; 2015 Jun; 29(3):321-8. PubMed ID: 25817734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
    J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?
    Muller C; Dimitrov Y; Imhoff O; Richter S; Ott J; Krummel T; Bazin-Kara D; Chantrel F; Hannedouche T; ;
    J Diabetes Complications; 2016; 30(4):675-80. PubMed ID: 26900098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Old age and the kidneys].
    Balázs E; Ruszwurm A; Székely M; Wittmann I; Nagy J
    Orv Hetil; 2008 Apr; 149(17):789-94. PubMed ID: 18426760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study.
    Tsai HJ; Hsu YH; Huang YW; Chang YK; Liu JS; Hsu CC
    Diabet Med; 2015 Mar; 32(3):382-90. PubMed ID: 25313684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of aging on kidney function and implications for medical practice].
    Rainfray M; Richard-Harston S; Salles-Montaudon N; Emeriau JP
    Presse Med; 2000 Jul 8-15; 29(24):1373-8. PubMed ID: 10938697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of non-steroidal anti-inflammatory drugs use and its association with chronic kidney disease: a cross-sectional survey in China.
    Pan Y; Zhang L; Wang F; Li X; Wang H;
    Nephrology (Carlton); 2014 Oct; 19(10):655-60. PubMed ID: 25196389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent changes of the kidneys: pharmacological implications.
    Mühlberg W; Platt D
    Gerontology; 1999; 45(5):243-53. PubMed ID: 10460985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of iatrogenic risk and screening of chronic kidney disease].
    Vasmant D
    Nephrol Ther; 2019 Nov; 15(6):465-467. PubMed ID: 31636049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and the aging population.
    Bartmańska M; Więcek A
    G Ital Nefrol; 2016 Feb; 33 Suppl 66():33.S66.11. PubMed ID: 26913879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
    Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
    Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and strategies for early detection and management of diabetic kidney disease.
    Radbill B; Murphy B; LeRoith D
    Mayo Clin Proc; 2008 Dec; 83(12):1373-81. PubMed ID: 19046557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decline in renal function in old age : Part of physiological aging versus age-related disease].
    Braun F; Brinkkötter PT
    Z Gerontol Geriatr; 2016 Aug; 49(6):469-76. PubMed ID: 27457360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction.
    Jerkić M; Vojvodić S; López-Novoa JM
    Int Urol Nephrol; 2001; 32(4):539-47. PubMed ID: 11989542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semicarbazide-sensitive amine oxidase and kidney disease.
    Wong MY; Saad S; Pollock C; Wong MG
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1637-44. PubMed ID: 24173357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.